Table 8.
Antimicrobial | Salmonella EUCAST ECOFFa | E. coli EUCAST ECOFFa | Concentration range, mg/L (no of wells) |
---|---|---|---|
Cefoxitin | > 8 | > 8 | 0.5–64 (8) |
Cefepime | NAb | > 0.125 | 0.06–32 (10) |
Cefotaxime + clavulanic acid | NA | NA | 0.06–64 (11) |
Ceftazidime + clavulanic acid | NA | NA | 0.125–128 (11) |
Meropenem | > 0.125 | > 0.125 | 0.03–16 (10) |
Temocillin | NAc | NAc | 0.5–64 (8) |
Imipenem | > 1 | > 0.5 | 0.12–16 (8) |
Ertapenem | > 0.06 | > 0.06 | 0.015–2 (8) |
Cefotaxime | > 0.5 | > 0.25 | 0.25–64 (9) |
Ceftazidime | > 2 | > 0.5 | 0.25–128 (10) |
EUCAST: European Committee on Antimicrobial Susceptibility Testing; ECOFFs: epidemiological cut‐off values; NA: not available.
EUCAST epidemiological cut‐off values as laid down in the Decision 2013/652/EU. For some antimicrobials these values have been updated (see below).
For cefepime, the cut‐off value used in the analysis for Salmonella was > 0.125 mg/L.
For temocillin, the cut‐off value used in the analysis was > 32 mg/L.